Management of perianal Crohn's disease.
Wise
Paul E
PE
Inflammatory Bowel Disease Center, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA.
Schwartz
David A
DA
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D003424:Crohn Disease / Q000175:diagnosis* / Q000628:therapy*; D013505:Digestive System Surgical Procedures; D019160:Endosonography; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D000069285:Infliximab; D008279:Magnetic Resonance Imaging; D008297:Male; D011349:Proctitis / Q000175:diagnosis* / Q000628:therapy*
D000900:Anti-Bacterial Agents; D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D007155:Immunologic Factors; D000069285:Infliximab